EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)

Stephen Henry Holland iD, Ricardo Carmona-Martinez, Kaela O'Connor iD, Daniel O'Neil iD, Andreas Roos iD, Sally Spendiff iD, Hanns Lochmüller

Biomolecules · 03.10.2024 · 14 (10) · 1252

DOI: 10.3390/biom14101252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 03.10.2024. Verfasst von Stephen Henry Holland und 6 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada. Hauptthemen laut MEDLINE: Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing), Muscle, Skeletal, Neuromuscular Junction, Receptors, Nicotinic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR) for Foundation Grant, Transnational Team Grant, Network Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The neuromuscular junction (NMJ) is the site where the motor neuron innervates skeletal muscle, enabling muscular contraction. Congenital myasthenic syndromes (CMS) arise when mutations in any of the approximately 35 known causative genes cause impaired neuromuscular transmission at the NMJ, resulting in fatigable muscle weakness. A subset of five of these CMS-causative genes are associated with protein glycosylation. Glutamine-fructose-6-phosphate transaminase 1 (Gfpt1) is the rate-limiting enzyme within the hexosamine biosynthetic pathway (HBP), a metabolic pathway that produces the precursors for glycosylation. We hypothesized that deficiency in Gfpt1 expression results in aberrant or reduced glycosylation, impairing the proper assembly and stability of key NMJ-associated proteins. Using both in vitro and in vivo Gfpt1-deficient models, we determined that the acetylcholine receptor delta subunit (AChRδ) has reduced expression and is hypo-glycosylated. Using laser capture microdissection, NMJs were harvested from Gfpt1 knockout mouse muscle. A lower-molecular-weight species of AChRδ was identified at the NMJ that was not detected in controls. Furthermore, Gfpt1-deficient muscle lysates showed impairment in protein O-GlcNAcylation and sialylation, suggesting that multiple glycan chains are impacted. Other key NMJ-associated proteins, in addition to AChRδ, may also be differentially glycosylated in Gfpt1-deficient muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)Muscle, SkeletalNeuromuscular JunctionReceptors, NicotinicAnimalsMiceGlycosylationMice, KnockoutMyasthenic Syndromes, Congenital

Stichwörter der Autor:innen

O-GlcNAcylationacetylcholine receptor delta subunit (AChRδ)congenital myasthenic syndrome (CMS)glutamine-fructose-6-phosphate transaminase 1 (Gfpt1)glycosylationneuromuscular junction (NMJ)

Substanzen

Gfpt1 protein, mouseGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)Receptors, Nicotinic

Autor:innen und Institutionen

  • Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8L1, Canada.
  • Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
  • Dr. Eric Poulin Center for Neuromuscular Disorders, Brain and Mind Research Institute, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
  • Department of Pediatric Neurology, Center for Neuromuscular Disorders, Centre for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, 45147 Essen, Germany.
  • Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University, 40225 Düsseldorf, Germany.
  • Faculty of Medicine, Medical Center, University of Freiburg, 79085 Freiburg, Germany.

ORCID-Profile: Stephen Henry Holland, Kaela O'Connor, Daniel O'Neil, Andreas Roos, Sally Spendiff

Förderung

  • Canadian Institutes of Health Research (CIHR) for Foundation Grant
  • Transnational Team Grant
  • Network Grant
  • Canada Foundation for Innovation
  • Canada Research Chairs program (Canada Research Chair in Neuromuscular Genomics and Health)
  • European Commission
  • Canada Research Coordinating Committee New Frontiers in Research Fund
  • Government of Canada, Canada First Research Excellence Fund (CFREF)

Zitieren

APA

Holland, S. H., Carmona-Martinez, R., O'Connor, K., O'Neil, D., Roos, A., Spendiff, S., & Lochmüller, H. (2024). A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ). Biomolecules, 14(10), 1252. https://doi.org/10.3390/biom14101252

Vancouver

Holland SH, Carmona-Martinez R, O'Connor K, O'Neil D, Roos A, Spendiff S, et al. A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ). Biomolecules. 2024;14(10):1252. doi:10.3390/biom14101252

BibTeX
@article{Holland2024,
  author = {Holland, Stephen Henry and Carmona-Martinez, Ricardo and O'Connor, Kaela and O'Neil, Daniel and Roos, Andreas and Spendiff, Sally and Lochmüller, Hanns},
  title = {A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ)},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {10},
  pages = {1252},
  doi = {10.3390/biom14101252}
}
Kostenlos starten →